Innovation & Growth - A case study of Pfizer

Essai , 2007 , 21 Pages , Note: 69% - B

Gestion d'entreprise - Direction d'entreprise, Management, Organisation

Pfizer Inc. is taken as case study for an innovative company in the pharmaceutical sector. Firstly, the author will look at its mission statement in relation to its key stakeholders. Secondly, the company’s overall strategy will be outlined regarding its positioning on the market as well the linkage to key theories which will be discussed and applied. The third part focuses on Pfizer’s operational issues. Finally a comparison of the strategic performance and application of theories between Microsoft and Pfizer, both, two highly innovative companies, will be made.

Pfizer, as the main case study, was chosen, because it can be defined as a highly innovative company, ranking globally the second by R&D expenditure on the DTI R&D scoreboard (see Appendix 1). However, according to the ‘Business Week’ the company ranks only on place 55 in the world’s most innovative companies, with a margin growth of 1.8% and stock returns of 9.9% between 1995 till 2005. (Business Week, 2006) This provides the evidence that Pfizer is an innovative company.

Inhaltsverzeichnis (Table of Contents)

• Introduction.
• Pfizer Inc.
  • Mission Statement - Pfizer
  • Strategic Statements & Layers of Pfizer..
  • Operational Dimension of Pfizer.….........
• Executive Summary ....
• Comparison: Microsoft & Pfizer.........

Zielsetzung und Themenschwerpunkte (Objectives and Key Themes)

This case study aims to analyze Pfizer Inc. as an innovative company. It explores the company's mission statement, strategic positioning, and operational aspects. The study also compares Pfizer's strategic performance and application of theories to those of Microsoft, another highly innovative company.

• Pfizer's mission statement and its alignment with key stakeholders.
• Pfizer's overall strategy and its positioning in the market.
• Pfizer's operational challenges and how they impact the company's success.
• A comparison of Pfizer's and Microsoft's strategic performance and application of key theories.
• The role of innovation and R&D in the pharmaceutical industry.

Zusammenfassung der Kapitel (Chapter Summaries)

The introduction sets the context for the case study, highlighting Pfizer's position as a highly innovative company and discussing the challenges faced by the pharmaceutical industry. Chapter 2 provides a detailed overview of Pfizer Inc., including its mission statement, strategic statements, and operational aspects. The executive summary provides a brief overview of the main findings of the case study. Finally, the comparison section analyzes the strategic performance and application of key theories in both Pfizer and Microsoft.

Schlüsselwörter (Keywords)

Innovation, pharmaceutical industry, R&D, strategic positioning, operational challenges, mission statement, stakeholders, Pfizer Inc., Microsoft, case study, competitive advantage, market share, global healthcare, drug development.

• Université: University of Sunderland (Faculty of Business and Law)
• Cours: Innovation & Growth
• Note: 69% - B
• Auteur: Miriam Mennen (Auteur)
• Année de publication: 2007
• Pages: 21
• N° de catalogue: V145364
• ISBN (ebook): 9783640568659
• ISBN (Livre): 9783640568581
• Langue: anglais
• mots-clé: Pfizer, Innovation, Microsoft, Competitive advantage, R&D, core competencies, M&A activities, stakeholder theory, pharmaceutical sector